Program Patents
The following are protected by patents in the United States and in foreign jurisdictions for ModernaTx, Inc.
mRNA-1273
COVID-19 VACCINE
US 10,898,574
US 10,703,789
US 10,702,600
US 10,577,403
US 10,442,756
US 10,266,485
US 10,064,959
US 9,868,692